SIFI > International Markets
International Markets
In the last years SIFI has undergone a virtuous growth of its business, evolving into an industrial group of companies, consolidating domestic leadership and expanding into international markets.

Internationalization for SIFI Group means exporting a brand that is synonymous with specialization and tradition in ophthalmology, quality and innovation, ethics and professionalism, scientific education and proximity to physicians and patients, high medical and technological contents and commitment to social responsibility.

SIFI group has acquired a strong presence in the Americas and in European countries, either through its own subsidiaries or through partnering commercial distributors.

Currently the global key markets include Mexico, Romania, Spain, UK, Russia and Turkey where SIFI already has a significant presence through exclusive distributors.

Direct subsidiaries are present in Mexico (Laboratorios SIFI de México S.A. de C.V.) and Romania (Oftafarma srl).

share & tag us with
#EyeCare #eyeinfo #health #innovation #business #eye #vision #leadership #pharma
#Development
“Vision is the art of seeing what is invisible to others.”
Jonathan Swift

 
 
Quality We CARE for patients; all patients, even those frequently left behind by the industry, such as individuals afflicted by rare diseases.   SIFI’s 80-year long history is distinguished...
 
SIFI Group has a Vigilance system that allows us to take full responsibility for our medical and non medical products, both marketed or in clinical development and to take appropriate...
 
Code of Ethics SIFI SpA S.I.F.I. - Società Industria Farmaceutica Italiana S.p.A. (Italian Pharmaceutical Industry Company) (Hereinafter also referred to as SIFI or the Company) has adopted...

On our Social Channels

From our News Center

Latest news from ophthalmic research as to the developing of an effective and safe treatment for Acanthamoeba Keratitis. At the annual meeting of the Association for Research in Vision and...
 

 

08 June

Degenerative eye diseases are often related to major pathologies diagnosed in advanced stages and they can also result from an incomplete “integrated approach”...
Follow Us!